Rockwell Medical, Inc. (RMTI)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.86
+2.25%
Mkt Cap $35.57M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $18.60M | $18.34M | -1.37% | $0.04 | -$0.01 | -125.00% | — | — |
| Q4 2025 Nov 12, 2025 | $18.58M | $15.93M | -14.29% | -$0.04 | -$0.05 | -25.00% | — | — |
| Q3 2025 Aug 14, 2025 | $16.33M | $16.07M | -1.60% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q2 2025 May 12, 2025 | $17.46M | $18.91M | +8.33% | -$0.03 | -$0.04 | -33.33% | — | — |
| Q1 2025 Mar 20, 2025 | $19.12M | $24.66M | +28.98% | $0.02 | -$0.02 | -200.00% | — | — |
| Q4 2024 Nov 12, 2024 | $26.50M | $28.32M | +6.85% | $0.01 | $0.05 | +400.00% | — | — |
| Q3 2024 Aug 8, 2024 | $23.23M | $25.83M | +11.20% | $0.00 | $0.01 | +125.73% | — | — |
| Q2 2024 May 14, 2024 | $21.70M | $22.68M | +4.50% | -$0.05 | -$0.02 | +60.00% | — | — |
| Q1 2024 Mar 21, 2024 | $22.63M | $22.09M | -2.37% | -$0.08 | $0.02 | +125.00% | — | — |
| Q4 2023 Nov 14, 2023 | $22.63M | $23.77M | +5.04% | -$0.12 | -$0.07 | +41.67% | — | — |
| Q3 2023 Aug 14, 2023 | $18.08M | $18.08M | +0.00% | -$0.12 | -$0.18 | -50.00% | — | — |
| Q2 2023 May 15, 2023 | $19.12M | $19.67M | +2.87% | -$0.18 | -$0.10 | +44.44% | — | — |
| Q1 2023 Mar 30, 2023 | $16.31M | $19.31M | +18.41% | -$0.39 | -$0.20 | +48.72% | — | — |
| Q4 2022 Nov 14, 2022 | $19.37M | $18.69M | -3.50% | -$0.37 | -$0.40 | -8.11% | — | — |
| Q3 2022 Aug 15, 2022 | $16.80M | $18.68M | +11.20% | -$0.88 | -$0.56 | +36.36% | — | — |
| Q2 2022 May 16, 2022 | $18.80M | $16.12M | -14.23% | -$0.99 | -$0.84 | +15.15% | — | — |
| Q2 2022 Apr 8, 2022 | $17.65M | $15.33M | -13.14% | -$0.99 | -$0.09 | +90.91% | — | — |
| Q4 2021 Nov 15, 2021 | $21.69M | $15.99M | -26.29% | -$0.77 | -$0.88 | -14.29% | — | — |
| Q3 2021 Aug 16, 2021 | $18.18M | $15.14M | -16.74% | -$0.88 | -$0.99 | -12.50% | — | — |
| Q2 2021 May 17, 2021 | $17.19M | $15.47M | -10.00% | -$0.99 | -$0.88 | +11.11% | — | — |